• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways.多特异性药物转运体 Slc22a8(Oat3)调节多种代谢和信号通路。
Drug Metab Dispos. 2013 Oct;41(10):1825-34. doi: 10.1124/dmd.113.052647. Epub 2013 Aug 6.
2
Unique metabolite preferences of the drug transporters OAT1 and OAT3 analyzed by machine learning.通过机器学习分析药物转运体 OAT1 和 OAT3 的独特代谢物偏好。
J Biol Chem. 2020 Feb 14;295(7):1829-1842. doi: 10.1074/jbc.RA119.010729. Epub 2020 Jan 2.
3
The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis.药物转运体OAT3(SLC22A8)与通过肠-肝-肾轴的内源性代谢物通讯。
J Biol Chem. 2017 Sep 22;292(38):15789-15803. doi: 10.1074/jbc.M117.796516. Epub 2017 Aug 1.
4
Coordinate regulation of systemic and kidney tryptophan metabolism by the drug transporters OAT1 and OAT3.药物转运体 OAT1 和 OAT3 对全身和肾脏色氨酸代谢的协调调节。
J Biol Chem. 2021 Jan-Jun;296:100575. doi: 10.1016/j.jbc.2021.100575. Epub 2021 Mar 21.
5
Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue.Oat1(Slc22a6)和 Oat3(Slc22a8)缺陷组织中脉络丛抗病毒处理中的有机阴离子转运途径。
Neurosci Lett. 2013 Feb 8;534:133-8. doi: 10.1016/j.neulet.2012.11.027. Epub 2012 Nov 27.
6
In Vivo Regulation of Small Molecule Natural Products, Antioxidants, and Nutrients by OAT1 and OAT3.OAT1 和 OAT3 对小分子天然产物、抗氧化剂和营养素的体内调节作用。
Nutrients. 2024 Jul 12;16(14):2242. doi: 10.3390/nu16142242.
7
Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling.分析发育和成熟肾脏的三维系统,阐明了 OAT1 和 OAT3 在抗病毒处理中的作用。
J Biol Chem. 2011 Jan 7;286(1):243-51. doi: 10.1074/jbc.M110.139949. Epub 2010 Oct 4.
8
Sex-dependent expression of Oat3 (Slc22a8) and Oat1 (Slc22a6) proteins in murine kidneys.在雄性和雌性小鼠肾脏中,Oat3(Slc22a8)和 Oat1(Slc22a6)蛋白的表达具有性别依赖性。
Am J Physiol Renal Physiol. 2013 Apr 15;304(8):F1114-26. doi: 10.1152/ajprenal.00201.2012. Epub 2013 Feb 6.
9
Organic anion transporters in remote sensing and organ crosstalk.有机阴离子转运体在遥感和器官串扰中的作用。
Pharmacol Ther. 2024 Nov;263:108723. doi: 10.1016/j.pharmthera.2024.108723. Epub 2024 Sep 14.
10
Hepatocyte nuclear factors 4α and 1α regulate kidney developmental expression of drug-metabolizing enzymes and drug transporters.肝细胞核因子 4α 和 1α 调节药物代谢酶和药物转运体在肾脏发育中的表达。
Mol Pharmacol. 2013 Dec;84(6):808-23. doi: 10.1124/mol.113.088229. Epub 2013 Sep 13.

引用本文的文献

1
From Discovery to Translation: Endogenous Substrates of OAT1 and OAT3 as Clinical Biomarkers for Renal Secretory Function.从发现到转化:OAT1和OAT3的内源性底物作为肾脏分泌功能的临床生物标志物
Clin Pharmacol Ther. 2025 Sep;118(3):693-704. doi: 10.1002/cpt.3719. Epub 2025 May 22.
2
Critical role of Slc22a8 in maintaining blood-brain barrier integrity after experimental cerebral ischemia-reperfusion.Slc22a8在实验性脑缺血再灌注后维持血脑屏障完整性中的关键作用
J Cereb Blood Flow Metab. 2025 Jan;45(1):85-101. doi: 10.1177/0271678X241264401. Epub 2024 Jul 28.
3
In Vivo Regulation of Small Molecule Natural Products, Antioxidants, and Nutrients by OAT1 and OAT3.OAT1 和 OAT3 对小分子天然产物、抗氧化剂和营养素的体内调节作用。
Nutrients. 2024 Jul 12;16(14):2242. doi: 10.3390/nu16142242.
4
Illuminating the function of the orphan transporter, SLC22A10, in humans and other primates.阐明孤儿转运蛋白 SLC22A10 在人类和其他灵长类动物中的功能。
Nat Commun. 2024 May 23;15(1):4380. doi: 10.1038/s41467-024-48569-7.
5
Effect of probenecid on blood levels and renal elimination of furosemide and endogenous compounds in rats: Discovery of putative organic anion transporter biomarkers.丙磺舒对大鼠呋塞米血药浓度和内源性化合物的肾排泄及潜在有机阴离子转运体生物标志物的影响。
Biochem Pharmacol. 2023 Dec;218:115867. doi: 10.1016/j.bcp.2023.115867. Epub 2023 Oct 20.
6
Chloroquine and Hydroxychloroquine, as Proteasome Inhibitors, Upregulate the Expression and Activity of Organic Anion Transporter 3.氯喹和羟氯喹作为蛋白酶体抑制剂,上调有机阴离子转运体3的表达和活性。
Pharmaceutics. 2023 Jun 14;15(6):1725. doi: 10.3390/pharmaceutics15061725.
7
Recent Advances in Synthetic Drugs and Natural Actives Interacting with OAT3.新型合成毒品和与 OAT3 相互作用的天然活性物质的最新进展
Molecules. 2023 Jun 13;28(12):4740. doi: 10.3390/molecules28124740.
8
Loss of the Kidney Urate Transporter, Urat1, Leads to Disrupted Redox Homeostasis in Mice.肾脏尿酸转运蛋白Urat1的缺失导致小鼠氧化还原稳态失衡。
Antioxidants (Basel). 2023 Mar 22;12(3):780. doi: 10.3390/antiox12030780.
9
Polymorphic renal transporters and cisplatin's toxicity in urinary bladder cancer patients: current perspectives and future directions.多态性肾脏转运体与顺铂在膀胱癌患者中的毒性:当前的观点和未来的方向。
Med Oncol. 2023 Jan 17;40(2):80. doi: 10.1007/s12032-022-01928-0.
10
Inhibition of proteasome, but not lysosome, upregulates organic anion transporter 3 in vitro and in vivo.蛋白酶体抑制而非溶酶体抑制可上调有机阴离子转运体 3 的体外和体内表达。
Biochem Pharmacol. 2023 Feb;208:115387. doi: 10.1016/j.bcp.2022.115387. Epub 2022 Dec 19.

本文引用的文献

1
Model-driven multi-omic data analysis elucidates metabolic immunomodulators of macrophage activation.基于模型的多组学数据分析揭示了巨噬细胞激活的代谢免疫调节剂。
Mol Syst Biol. 2012 Jun 26;8:558. doi: 10.1038/msb.2012.21.
2
A role for the organic anion transporter OAT3 in renal creatinine secretion in mice.有机阴离子转运体 OAT3 在小鼠肾脏肌酐分泌中的作用。
Am J Physiol Renal Physiol. 2012 May 15;302(10):F1293-9. doi: 10.1152/ajprenal.00013.2012. Epub 2012 Feb 15.
3
Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies.近年来肾脏尿酸转运的研究进展:全基因组关联研究提示候选转运体的特征。
Clin Exp Nephrol. 2012 Feb;16(1):89-95. doi: 10.1007/s10157-011-0532-z. Epub 2011 Nov 1.
4
Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I.有机阴离子转运体 1 和 3 在马兜铃酸 I 肾蓄积和毒性中的关键作用。
Mol Pharm. 2011 Dec 5;8(6):2183-92. doi: 10.1021/mp100418u. Epub 2011 Oct 20.
5
Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0.基于约束的模型对细胞代谢进行定量预测:COBRA Toolbox v2.0。
Nat Protoc. 2011 Aug 4;6(9):1290-307. doi: 10.1038/nprot.2011.308.
6
Linkage of organic anion transporter-1 to metabolic pathways through integrated "omics"-driven network and functional analysis.通过整合的“组学”驱动网络和功能分析将有机阴离子转运蛋白 1 与代谢途径联系起来。
J Biol Chem. 2011 Sep 9;286(36):31522-31. doi: 10.1074/jbc.M111.272534. Epub 2011 Jul 12.
7
Interaction of hydroxycinnamic acids and their conjugates with organic anion transporters and ATP-binding cassette transporters.羟基肉桂酸及其缀合物与有机阴离子转运体和 ATP 结合盒转运体的相互作用。
Mol Nutr Food Res. 2011 Jul;55(7):979-88. doi: 10.1002/mnfr.201000652. Epub 2011 Apr 29.
8
Functional maturation of drug transporters in the developing, neonatal, and postnatal kidney.药物转运体在发育、新生儿和产后肾脏中的功能成熟。
Mol Pharmacol. 2011 Jul;80(1):147-54. doi: 10.1124/mol.110.070680. Epub 2011 Apr 14.
9
Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1).非靶向代谢组学鉴定肠菌代谢物和潜在尿毒症毒素为有机阴离子转运蛋白 1(Oat1)的底物。
J Proteome Res. 2011 Jun 3;10(6):2842-51. doi: 10.1021/pr200093w. Epub 2011 Apr 22.
10
Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis.通过溶质载体和 ATP 结合盒式药物转运体途径的远程通讯:远程感应和信号假说的最新进展。
Mol Pharmacol. 2011 May;79(5):795-805. doi: 10.1124/mol.110.070607. Epub 2011 Feb 11.

多特异性药物转运体 Slc22a8(Oat3)调节多种代谢和信号通路。

Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways.

机构信息

Departments of Pediatrics (H.C.L., K.T.B., S.K.N.), Medicine, Division of Nephrology and Hypertension (W.W., S.A.E., S.K.N.), Cellular and Molecular Medicine (S.K.N.), and Bioengineering (N.J., B.O.P., S.K.N.), University of California, San Diego, La Jolla, California.

出版信息

Drug Metab Dispos. 2013 Oct;41(10):1825-34. doi: 10.1124/dmd.113.052647. Epub 2013 Aug 6.

DOI:10.1124/dmd.113.052647
PMID:23920220
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3781372/
Abstract

Multispecific drug transporters of the solute carrier and ATP-binding cassette families are highly conserved through evolution, but their true physiologic role remains unclear. Analyses of the organic anion transporter 3 (OAT3; encoded by Slc22a8/Oat3, originally Roct) knockout mouse have confirmed its critical role in the renal handling of common drugs (e.g., antibiotics, antivirals, diuretics) and toxins. Previous targeted metabolomics of the knockout of the closely related Oat1 have demonstrated a central metabolic role, but the same approach with Oat3 failed to reveal a similar set of endogenous substrates. Nevertheless, the Oat3 knockout is the only Oat described so far with a physiologically significant phenotype, suggesting the disturbance of metabolic or signaling pathways. Here we analyzed global gene expression in Oat3 knockout tissue, which implicated OAT3 in phase I and phase II metabolism (drug metabolizing enzymes or DMEs), as well as signaling pathways. Metabolic reconstruction with the recently developed "mouse Recon1" supported the involvement of Oat3 in the aforementioned pathways. Untargeted metabolomics were used to determine whether the predicted metabolic alterations could be confirmed. Many significant changes were observed; several metabolites were tested for direct interaction with mOAT3, whereas others were supported by published data. Oat3 thus appears critical for the handling of phase I (hydroxylation) and phase II (glucuronidation) metabolites. Oat3 also plays a role in bioenergetic pathways (e.g., the tricarboxylic acid cycle), as well as those involving vitamins (e.g., folate), steroids, prostaglandins, gut microbiome products, uremic toxins, cyclic nucleotides, amino acids, glycans, and possibly hyaluronic acid. The data seemingly consistent with the Remote Sensing and Signaling Hypothesis (Ahn and Nigam, 2009; Wu et al., 2011), also suggests that Oat3 is essential for the handling of dietary flavonoids and antioxidants.

摘要

多特异性药物转运蛋白属于溶质载体和 ATP 结合盒家族,在进化过程中高度保守,但它们的确切生理功能仍不清楚。有机阴离子转运蛋白 3(OAT3;由 Slc22a8/Oat3 编码,最初称为 Roct)敲除小鼠的分析证实了其在肾脏处理常见药物(如抗生素、抗病毒药、利尿剂)和毒素中的关键作用。先前对密切相关的 Oat1 敲除的靶向代谢组学研究表明其具有重要的中心代谢作用,但对 Oat3 采用相同方法却未能揭示出一组类似的内源性底物。然而,到目前为止,Oat3 是唯一具有生理意义表型的 Oat,这表明其代谢或信号通路受到干扰。在这里,我们分析了 Oat3 敲除组织中的全基因表达,这表明 OAT3 参与了 I 相和 II 相代谢(药物代谢酶或 DMEs)以及信号通路。最近开发的“mouse Recon1”进行的代谢重建支持 Oat3 参与上述途径。非靶向代谢组学用于确定是否可以证实预测的代谢变化。观察到许多显著变化;对几种代谢物进行了直接与 mOAT3 相互作用的测试,而其他代谢物则得到了已发表数据的支持。因此,Oat3 似乎对 I 相(羟化)和 II 相(葡萄糖醛酸化)代谢物的处理至关重要。Oat3 还在能量代谢途径(如三羧酸循环)以及涉及维生素(如叶酸)、类固醇、前列腺素、肠道微生物组产物、尿毒症毒素、环核苷酸、氨基酸、聚糖和可能的透明质酸的途径中发挥作用。这些数据似乎与远程传感和信号假说(Ahn 和 Nigam,2009;Wu 等人,2011)一致,也表明 Oat3 对于处理膳食类黄酮和抗氧化剂是必需的。